Studies

CellWell record HH-526172

Adipose triglyceride lipase driven lipolysis as a targetable metabolic vulnerability in prostate cancer with intrinsic metabolic inflexibility

Andreas Tiefenbacher; Madeleine Gudenus; Daniel Valcanover; Barbara Neudert; Raheleh Sheibani-Tezerji; Theresa Mendrina; Jessica Kalla; Laura Pajed; Kristina Draganić; Andrea Haitel; Astrid Haase; Markus Hartenbach; Sazan Rasul; Walter Berger; Rolf Breinbauer; Gernot Grabner; Martina Schweiger; Eva Compérat; Gerda Egger

2026

In plain language

In prostate cancer, PSMA-high tumors showed ATGL upregulation, and ATGL inhibition most strongly reduced proliferation of metabolically inflexible LNCaP cells.

Evidence
Emerging
Design
Primary research (design unspecified)

Read it on PubMed

Powered by CellWell

Cite this record: https://thecellwell.org/studies/HH-526172

Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.

This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.